Skip to main content
OpenTrials

Clinical trial condition

Urethral Diseases

Explore clinical trials studying Urethral Diseases. Study availability and eligibility vary by location and protocol.

166 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Urethral Diseases trial results

Completed

Memokath® 044TW Stent for Treatment of Urethral Stricture

NCT00270504

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +5 more
Locations
  • Jack McAninch San Francisco, California, United States
  • Mississippi Urology Jackson, Mississippi, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Bryn Mawr Urology Bryn Mawr, Pennsylvania, United States
View Trial Details
Completed

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

NCT00077688

Conditions
Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

NCT05092958

Conditions
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, +30 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Palo Alto Medical Foundation-Fremont Fremont, California, United States
View all 275 locations
View Trial Details
Active, Not Recruiting

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

NCT03237780

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Locally Advanced Bladder Urothelial Carcinoma, +36 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Keck Medicine of USC Buena Park Buena Park, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

NCT03499964

Conditions
Bites and Stings, Chemically-Induced Disorders, Female Urogenital Diseases, +13 more
Locations
  • Academic Urology and Urogynecology of Arizona Phoenix, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Advanced Urology Institute Daytona Beach, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 22 locations
View Trial Details

Related conditions